Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.60 |
| ▸ | HTT | P42858 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | HPGD | P15428 | 2/20 | 0.60 |
| ▸ | ESR1 | P03372 | 1/20 | 0.60 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.60 |
| ▸ | PKM | P14618 | 1/20 | 0.60 |
| ▸ | CA1 | P00915 | 4/20 | 0.57 |
| ▸ | CA2 | P00918 | 4/20 | 0.57 |
| ▸ | CA12 | O43570 | 3/20 | 0.57 |
| ▸ | CA9 | Q16790 | 3/20 | 0.57 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.57 |
| ▸ | CA7 | P43166 | 2/20 | 0.57 |
| ▸ | CA3 | P07451 | 2/20 | 0.57 |
| ▸ | TYR | P14679 | 2/20 | 0.57 |
| ▸ | CA4 | P22748 | 2/20 | 0.57 |
| ▸ | CA5A | P35218 | 2/20 | 0.57 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.57 |
| ▸ | DRD1 | P21728 | 1/20 | 0.57 |
| ▸ | CA6 | P23280 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenol SCHEMBL28080984 | 0.81 | CES2 (0.56) | MAPTLMNAHPGDPKMCA1 | |
| SCHEMBL1442016 | 0.79 | MAPT (0.44) | MAPTLMNACA1CA2CA12 | |
| SCHEMBL5842596 | 0.77 | TSHR (0.71) | CA1CA2CA12CA9CA14 | |
| SCHEMBL162830 | 0.77 | PARP10 (0.74) | MAPTHTTLMNAHPGDESR1 | |
| SCHEMBL28823636 | 0.77 | PARP10 (0.74) | MAPTHTTLMNAHPGDESR1 | |
| Hydroquinone SCHEMBL8674228 | 0.77 | PARP10 (0.74) | MAPTHTTLMNAHPGDESR1 | |
| SCHEMBL699850 | 0.75 | LMNA (1.00) | MAPTHTTLMNAHPGDESR1 | |
| SCHEMBL18423 | 0.75 | LMNA (1.00) | MAPTHTTLMNAHPGDESR1 | |
| SCHEMBL181662 | 0.75 | CES2 (0.79) | MAPTHTTLMNAHPGDESR1 | |
| Paraben SCHEMBL8968826 | 0.74 | CA2 (0.89) | MAPTHTTLMNAHPGDESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 592 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240180932-A1 | SUBSTITUTED RESORCYLIC ACID COMPOUNDS IN THE MANAGEMENT OF AGEING AND RELATED DISORDERS | NESTLE SA (CH) | 2024-06-06 | — | — | US | claimed |
| US-11993801-B2 | Base-modified nucleotides as substrates for TdT-based enzymatic nucleic acid synthesis | ILLUMINA SINGAPORE PTE. LTD. (SG) | 2024-05-28 | — | — | US | claimed |
| US-11897977-B2 | Photolabile barbiturate compounds | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2024-02-13 | — | — | US | claimed |
| EP-4313017-A1 | SUBSTITUTED RESORCYLIC ACID COMPOUNDS IN THE MANAGEMENT OF AGEING AND RELATED DISORDERS | Société des Produits Nestlé S.A. (CH) | 2024-02-07 | — | — | EP | claimed |
| US-20230414638-A1 | SUBSTITUTED RESORCYLIC ACID COMPOUNDS AS AMPK ACTIVATOR AND USES THEREOF | NESTLE SA (CH) | 2023-12-28 | — | — | US | claimed |
| US-20230346942-A1 | MACROMOLECULAR PRODRUGS FOR LIGHT-EMITTING DIODES AND USES THEREOF | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2023-11-02 | — | — | US | claimed |
| CN-116981452-A | Substituted resorcinol compounds for the management of aging and related disorders | 雀巢产品有限公司 | 2023-10-31 | — | — | CN | claimed |
| CN-116761791-A | Substituted resorcinol compounds as AMPK activators and uses thereof | 雀巢产品有限公司 | 2023-09-15 | — | — | CN | claimed |
| EP-4185707-A1 | BASE-MODIFIED NUCLEOTIDES AS SUBSTRATES FOR TDT-BASED ENZYMATIC NUCLEIC ACID | Illumina Singapore Pte Ltd (SG) | 2023-05-31 | — | — | EP | claimed |
| CN-115867670-A | Base-modified nucleotides as substrates for TDT-based enzyme nucleic acids | 伊鲁米纳新加坡有限公司 | 2023-03-28 | — | — | CN | claimed |
| US-20060008907-A1 | Control of gene expression via light activated RNA interference | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2006-01-12 | — | — | US | claimed |
| EP-1383748-A2 | NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2004-01-28 | — | — | EP | claimed |
| WO-2002051983-A2 | NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2002-07-04 | — | — | WO | claimed |
| EP-1073764-A4 | MEMBRANE-PERMEANT PHOSPHOINOSITIDES | UNIV CALIFORNIA (US) | 2001-11-14 | — | — | EP | claimed |
| EP-1073764-A1 | MEMBRANE-PERMEANT PHOSPHOINOSITIDES | The Regents of the University of California (US) | 2001-02-07 | — | — | EP | claimed |
| WO-1999055903-A1 | MEMBRANE-PERMEANT PHOSPHOINOSITIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1999-11-04 | — | — | WO | claimed |
| US-5955453-A | Membrane-permeant phosphoinositides | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1999-09-21 | — | — | US | claimed |
| US-4704396-A | 5-HYDROXYTRYPTAMINE; HYPOTENSIVES | ELI LILLY AND COMPANY (US) | 1987-11-03 | — | — | US | claimed |
| EP-0228876-A2 | Esters of dihydrolysergic acid and related compounds | ELI LILLY AND COMPANY (US) | 1987-07-15 | — | — | EP | claimed |
| US-4075340-A | ANTIINFLAMMATORY, ANTIARRYTHMIC, ANTICOAGULANTS | PARCOR (FR) | 1978-02-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230414638-A1 | SUBSTITUTED RESORCYLIC ACID COMPOUNDS AS AMPK ACTIVATOR AND USES THEREOF | PRKAG2, PRKAB2, PRKAG1 | MAPT 2537/4885HTT 3881/4885LMNA 4223/4885 |
| US-11897977-B2 | Photolabile barbiturate compounds | PPOX, CBR1, CBR3 | MAPT 70/4885HTT 2868/4885LMNA 3594/4885 |
| US-20240180932-A1 | SUBSTITUTED RESORCYLIC ACID COMPOUNDS IN THE MANAGEMENT OF AGEING AND RELATED DISORDERS | HSPA9, CS, SQSTM1 | MAPT 776/4885HTT 129/4885LMNA 2758/4885 |
| US-20230346942-A1 | MACROMOLECULAR PRODRUGS FOR LIGHT-EMITTING DIODES AND USES THEREOF | CRY1, MAPT, PYGL | MAPT 2/4885HTT 838/4885LMNA 699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.